SANTA FE, N.M. (AP) - New Mexico Attorney General Gary King says the state has reached a multimillion-dollar settlement with a manufacturer over alleged misrepresentations regarding a diabetes drug.
King announced Monday that New Mexico should net close to $19 million from the deal.
Prosecutors alleged that GlaxoSmithKline downplayed or misrepresented the risk of cardiovascular disease associated with the use of Avandia.
King says the settlement returns about $15 million related to consumer claims and about $3.8 million to offset Medicaid expenditures on the drug.
(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)